Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer.

Saved in:
Bibliographic Details
Title: Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer.
Authors: Yan, Jingsong1 (AUTHOR), Yang, Xiao2 (AUTHOR), Lu, Jiabin3 (AUTHOR), Wu, Shasha1 (AUTHOR), Wang, Yanchen4 (AUTHOR), Du, Yuyang1 (AUTHOR), Zheng, Jingyi4 (AUTHOR), Wang, Fenfen1 (AUTHOR), Gao, Han1 (AUTHOR), Yang, Hui1 (AUTHOR), Xi, Shaoyan3 (AUTHOR) xishy@sysucc.org.cn, Li, Yan1,4 (AUTHOR) liyan181@smu.edu.cn
Source: Cancer Cell International. 6/13/2025, Vol. 25 Issue 1, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752867
DOI:10.1186/s12935-025-03843-6